

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.90963994 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.25092156 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.25092156 |
| 4 | positive regulation of B cell differentiation (GO:0045579) | 5.20525901 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.04948612 |
| 6 | B cell receptor signaling pathway (GO:0050853) | 5.04232003 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.95849923 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.88527490 |
| 9 | leukocyte aggregation (GO:0070486) | 4.73894205 |
| 10 | mast cell activation (GO:0045576) | 4.73679008 |
| 11 | regulation of B cell differentiation (GO:0045577) | 4.60344406 |
| 12 | negative regulation of phagocytosis (GO:0050765) | 4.56162872 |
| 13 | mast cell activation involved in immune response (GO:0002279) | 4.37646397 |
| 14 | mast cell degranulation (GO:0043303) | 4.37646397 |
| 15 | detection of other organism (GO:0098543) | 4.32601619 |
| 16 | detection of bacterium (GO:0016045) | 4.31139925 |
| 17 | negative regulation of cell killing (GO:0031342) | 4.30443888 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.30443888 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 4.25104979 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.23340415 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 4.14255155 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 4.04459689 |
| 23 | regulation of gamma-delta T cell activation (GO:0046643) | 3.95671649 |
| 24 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.94806408 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.93374763 |
| 26 | response to interleukin-15 (GO:0070672) | 3.82551799 |
| 27 | T cell migration (GO:0072678) | 3.81911746 |
| 28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.81791246 |
| 29 | defense response to protozoan (GO:0042832) | 3.78721898 |
| 30 | T cell homeostasis (GO:0043029) | 3.74363816 |
| 31 | megakaryocyte development (GO:0035855) | 3.70550807 |
| 32 | respiratory burst (GO:0045730) | 3.66551417 |
| 33 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.62068097 |
| 34 | cellular response to interleukin-15 (GO:0071350) | 3.59834361 |
| 35 | response to protozoan (GO:0001562) | 3.56077968 |
| 36 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.55411176 |
| 37 | immunoglobulin mediated immune response (GO:0016064) | 3.54190798 |
| 38 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.51441761 |
| 39 | neutrophil activation (GO:0042119) | 3.51365336 |
| 40 | leukocyte degranulation (GO:0043299) | 3.49385893 |
| 41 | negative regulation of T cell mediated immunity (GO:0002710) | 3.49088752 |
| 42 | negative thymic T cell selection (GO:0045060) | 3.46351659 |
| 43 | detection of external biotic stimulus (GO:0098581) | 3.44613526 |
| 44 | mature B cell differentiation (GO:0002335) | 3.42215326 |
| 45 | negative T cell selection (GO:0043383) | 3.41898586 |
| 46 | myeloid cell activation involved in immune response (GO:0002275) | 3.40758542 |
| 47 | regulation of T cell tolerance induction (GO:0002664) | 3.37574652 |
| 48 | neutrophil mediated immunity (GO:0002446) | 3.36380402 |
| 49 | lymphocyte homeostasis (GO:0002260) | 3.35056149 |
| 50 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.34875781 |
| 51 | positive regulation of granulocyte differentiation (GO:0030854) | 3.32661525 |
| 52 | angiogenesis involved in wound healing (GO:0060055) | 3.31024515 |
| 53 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.29777939 |
| 54 | response to host immune response (GO:0052572) | 3.29777939 |
| 55 | positive thymic T cell selection (GO:0045059) | 3.29544120 |
| 56 | leukocyte homeostasis (GO:0001776) | 3.24641588 |
| 57 | regulation of tolerance induction (GO:0002643) | 3.23731653 |
| 58 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.22585947 |
| 59 | B cell homeostasis (GO:0001782) | 3.21730864 |
| 60 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.20730610 |
| 61 | cellular extravasation (GO:0045123) | 3.20249565 |
| 62 | mature B cell differentiation involved in immune response (GO:0002313) | 3.19562091 |
| 63 | interferon-gamma production (GO:0032609) | 3.16985792 |
| 64 | regulation of leukocyte degranulation (GO:0043300) | 3.16627327 |
| 65 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.16354805 |
| 66 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.16332163 |
| 67 | granulocyte activation (GO:0036230) | 3.13292393 |
| 68 | tolerance induction (GO:0002507) | 3.12797832 |
| 69 | negative regulation of interleukin-6 production (GO:0032715) | 3.10572216 |
| 70 | positive regulation of mast cell activation (GO:0033005) | 3.04412621 |
| 71 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.03776778 |
| 72 | negative regulation of innate immune response (GO:0045824) | 3.03446036 |
| 73 | detection of biotic stimulus (GO:0009595) | 3.03365515 |
| 74 | macrophage activation (GO:0042116) | 3.02673752 |
| 75 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.02328129 |
| 76 | Peyers patch development (GO:0048541) | 3.02328129 |
| 77 | myeloid dendritic cell activation (GO:0001773) | 3.01918505 |
| 78 | microglial cell activation (GO:0001774) | 3.01614270 |
| 79 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.00404756 |
| 80 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.00254725 |
| 81 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.99573177 |
| 82 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.98159946 |
| 83 | response to host (GO:0075136) | 2.98159946 |
| 84 | response to host defenses (GO:0052200) | 2.98159946 |
| 85 | regulation of antigen processing and presentation (GO:0002577) | 2.97714887 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.96971946 |
| 87 | germinal center formation (GO:0002467) | 2.95105308 |
| 88 | activated T cell proliferation (GO:0050798) | 2.93340860 |
| 89 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.91954734 |
| 90 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.91876118 |
| 91 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.91876118 |
| 92 | B cell mediated immunity (GO:0019724) | 2.90442488 |
| 93 | response to peptidoglycan (GO:0032494) | 2.87476977 |
| 94 | histone H3-K4 trimethylation (GO:0080182) | 2.86236493 |
| 95 | mannose metabolic process (GO:0006013) | 2.85693731 |
| 96 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.85421502 |
| 97 | T cell selection (GO:0045058) | 2.84836877 |
| 98 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.84194173 |
| 99 | detection of molecule of bacterial origin (GO:0032490) | 2.83898630 |
| 100 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.82871422 |
| 101 | T cell receptor signaling pathway (GO:0050852) | 2.81160091 |
| 102 | myeloid dendritic cell differentiation (GO:0043011) | 2.79614119 |
| 103 | positive T cell selection (GO:0043368) | 2.78957646 |
| 104 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.78486589 |
| 105 | response to type I interferon (GO:0034340) | 2.78439872 |
| 106 | positive regulation of tolerance induction (GO:0002645) | 2.77016950 |
| 107 | cellular response to type I interferon (GO:0071357) | 2.75714359 |
| 108 | type I interferon signaling pathway (GO:0060337) | 2.75714359 |
| 109 | response to muramyl dipeptide (GO:0032495) | 2.75690954 |
| 110 | thymic T cell selection (GO:0045061) | 2.75281266 |
| 111 | natural killer cell differentiation (GO:0001779) | 2.75086268 |
| 112 | ribosomal small subunit assembly (GO:0000028) | 2.74075820 |
| 113 | positive regulation by symbiont of host defense response (GO:0052509) | 2.73702746 |
| 114 | modulation by symbiont of host defense response (GO:0052031) | 2.73702746 |
| 115 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.73702746 |
| 116 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.73702746 |
| 117 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.73702746 |
| 118 | modulation by symbiont of host immune response (GO:0052553) | 2.73702746 |
| 119 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.72501324 |
| 120 | positive regulation of antigen processing and presentation (GO:0002579) | 2.72287609 |
| 121 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.70077168 |
| 122 | regulation of mast cell activation (GO:0033003) | 2.69851009 |
| 123 | regulation of granulocyte differentiation (GO:0030852) | 2.68015349 |
| 124 | myeloid leukocyte mediated immunity (GO:0002444) | 2.67975947 |
| 125 | cellular response to zinc ion (GO:0071294) | 2.66209095 |
| 126 | lymph node development (GO:0048535) | 2.66138421 |
| 127 | leukocyte cell-cell adhesion (GO:0007159) | 2.65126606 |
| 128 | definitive hemopoiesis (GO:0060216) | 2.65077680 |
| 129 | NIK/NF-kappaB signaling (GO:0038061) | 2.64670909 |
| 130 | positive regulation of interleukin-2 production (GO:0032743) | 2.63121540 |
| 131 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.62829556 |
| 132 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.62107086 |
| 133 | positive regulation of B cell activation (GO:0050871) | 2.61858004 |
| 134 | regulation of mast cell degranulation (GO:0043304) | 2.61633839 |
| 135 | myeloid leukocyte activation (GO:0002274) | 2.61271537 |
| 136 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.60978533 |
| 137 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.60272249 |
| 138 | natural killer cell activation (GO:0030101) | 2.59804170 |
| 139 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.58368025 |
| 140 | negative regulation of B cell proliferation (GO:0030889) | 2.57496446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.08087530 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.79689044 |
| 3 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.23403015 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.15051141 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.11209917 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.94202553 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.86682436 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.76507594 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.74223711 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.40879989 |
| 11 | * VDR_21846776_ChIP-Seq_THP-1_Human | 3.35091593 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 3.25550756 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.05412443 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.93565582 |
| 15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.92025755 |
| 16 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.83528249 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.69565161 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.61978549 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.58258760 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.58050041 |
| 21 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.57566694 |
| 22 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55993659 |
| 23 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.52370445 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.51314561 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.44068747 |
| 26 | * MAF_26560356_Chip-Seq_TH1_Human | 2.35480679 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.31688501 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.30282550 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 2.28189740 |
| 30 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.23962663 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22055434 |
| 32 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.21421931 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.20794043 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.15553990 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13757581 |
| 36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.06896152 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98659469 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.98347015 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.97701520 |
| 40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.89196259 |
| 41 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88213882 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.87210564 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.80059106 |
| 44 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.76885060 |
| 45 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76187249 |
| 46 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73669997 |
| 47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.68247214 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.53977626 |
| 49 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.51153885 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.50666325 |
| 51 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.49346524 |
| 52 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47231987 |
| 53 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46943166 |
| 54 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.45279898 |
| 55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.44971066 |
| 56 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44224552 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43568303 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.43159294 |
| 59 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.42219333 |
| 60 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.40917637 |
| 61 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.40156211 |
| 62 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.39204710 |
| 63 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.38761004 |
| 64 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38115135 |
| 65 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.37663847 |
| 66 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.35724880 |
| 67 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.34498870 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31683647 |
| 69 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30552985 |
| 70 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29552343 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28581928 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26153011 |
| 73 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.24848667 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23763608 |
| 75 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.21602016 |
| 76 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20303386 |
| 77 | * P68_20966046_ChIP-Seq_HELA_Human | 1.19778350 |
| 78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.19387576 |
| 79 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18675548 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17000732 |
| 81 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.14963626 |
| 82 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.14894184 |
| 83 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14552542 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14023882 |
| 85 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11804411 |
| 86 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10213651 |
| 87 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10207159 |
| 88 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10137045 |
| 89 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06912230 |
| 90 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.04904516 |
| 91 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.04723064 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02460787 |
| 93 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00756575 |
| 94 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.00413528 |
| 95 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98000632 |
| 96 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96592032 |
| 97 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95471948 |
| 98 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95056564 |
| 99 | KDM2B_26808549_Chip-Seq_K562_Human | 0.93949107 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93801304 |
| 101 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.93729720 |
| 102 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93279900 |
| 103 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92954489 |
| 104 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.92720408 |
| 105 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92182758 |
| 106 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.91521990 |
| 107 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91500337 |
| 108 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91094932 |
| 109 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90457052 |
| 110 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.89569750 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87240414 |
| 112 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85499240 |
| 113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82753887 |
| 114 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80843715 |
| 115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79231290 |
| 116 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.79189150 |
| 117 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.74749045 |
| 118 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.73717215 |
| 119 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.73064534 |
| 120 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.71378638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.07810129 |
| 2 | MP0002396_abnormal_hematopoietic_system | 3.39298434 |
| 3 | MP0005671_abnormal_response_to | 3.21624234 |
| 4 | MP0000685_abnormal_immune_system | 3.10843925 |
| 5 | MP0001800_abnormal_humoral_immune | 3.08321679 |
| 6 | MP0005387_immune_system_phenotype | 2.79429601 |
| 7 | MP0001790_abnormal_immune_system | 2.79429601 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.79388334 |
| 9 | MP0002452_abnormal_antigen_presenting | 2.72512862 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.71010328 |
| 11 | MP0009785_altered_susceptibility_to | 2.68227727 |
| 12 | MP0001819_abnormal_immune_cell | 2.67321926 |
| 13 | MP0002723_abnormal_immune_serum | 2.66989782 |
| 14 | MP0003763_abnormal_thymus_physiology | 2.61980894 |
| 15 | MP0003436_decreased_susceptibility_to | 2.58328994 |
| 16 | MP0005464_abnormal_platelet_physiology | 2.56331685 |
| 17 | MP0005025_abnormal_response_to | 2.55713826 |
| 18 | MP0002398_abnormal_bone_marrow | 2.55567098 |
| 19 | MP0002419_abnormal_innate_immunity | 2.54115554 |
| 20 | MP0005174_abnormal_tail_pigmentation | 2.51096167 |
| 21 | MP0003303_peritoneal_inflammation | 2.40535080 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.32215763 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.29834176 |
| 24 | MP0000716_abnormal_immune_system | 2.28048763 |
| 25 | MP0000689_abnormal_spleen_morphology | 2.14011511 |
| 26 | MP0004808_abnormal_hematopoietic_stem | 2.10453562 |
| 27 | MP0002166_altered_tumor_susceptibility | 2.09629719 |
| 28 | MP0000569_abnormal_digit_pigmentation | 2.03875874 |
| 29 | MP0002722_abnormal_immune_system | 2.02969448 |
| 30 | MP0000465_gastrointestinal_hemorrhage | 2.00635669 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.95000132 |
| 32 | MP0002429_abnormal_blood_cell | 1.91363402 |
| 33 | MP0005409_darkened_coat_color | 1.86448577 |
| 34 | MP0000703_abnormal_thymus_morphology | 1.82550712 |
| 35 | MP0005397_hematopoietic_system_phenotyp | 1.81533762 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.81533762 |
| 37 | MP0002405_respiratory_system_inflammati | 1.79246052 |
| 38 | MP0001873_stomach_inflammation | 1.75617582 |
| 39 | MP0000015_abnormal_ear_pigmentation | 1.73459057 |
| 40 | MP0005075_abnormal_melanosome_morpholog | 1.70670578 |
| 41 | MP0006082_CNS_inflammation | 1.70254452 |
| 42 | MP0008260_abnormal_autophagy | 1.70252840 |
| 43 | MP0009278_abnormal_bone_marrow | 1.69674946 |
| 44 | MP0002006_tumorigenesis | 1.67300987 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.63681406 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.61579928 |
| 47 | MP0003866_abnormal_defecation | 1.60542666 |
| 48 | MP0009840_abnormal_foam_cell | 1.57601976 |
| 49 | MP0008057_abnormal_DNA_replication | 1.55229615 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.54539131 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.53105719 |
| 52 | MP0005058_abnormal_lysosome_morphology | 1.49275158 |
| 53 | MP0005310_abnormal_salivary_gland | 1.48503478 |
| 54 | MP0003724_increased_susceptibility_to | 1.46822867 |
| 55 | MP0001986_abnormal_taste_sensitivity | 1.43621030 |
| 56 | MP0004947_skin_inflammation | 1.36519137 |
| 57 | MP0004510_myositis | 1.30617078 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.28220954 |
| 59 | MP0005451_abnormal_body_composition | 1.27634965 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.27373130 |
| 61 | MP0001853_heart_inflammation | 1.26495927 |
| 62 | MP0003828_pulmonary_edema | 1.25154020 |
| 63 | MP0002095_abnormal_skin_pigmentation | 1.24963563 |
| 64 | MP0002933_joint_inflammation | 1.16999847 |
| 65 | MP0000920_abnormal_myelination | 1.15273160 |
| 66 | MP0000490_abnormal_crypts_of | 1.15222395 |
| 67 | MP0002132_abnormal_respiratory_system | 1.14529067 |
| 68 | MP0001851_eye_inflammation | 1.10463739 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 1.07211024 |
| 70 | MP0008469_abnormal_protein_level | 1.07074161 |
| 71 | MP0001533_abnormal_skeleton_physiology | 1.03977867 |
| 72 | MP0000858_altered_metastatic_potential | 0.97038747 |
| 73 | MP0004883_abnormal_blood_vessel | 0.94397146 |
| 74 | MP0010094_abnormal_chromosome_stability | 0.94042349 |
| 75 | MP0004859_abnormal_synaptic_plasticity | 0.93095760 |
| 76 | MP0002019_abnormal_tumor_incidence | 0.92829223 |
| 77 | MP0010307_abnormal_tumor_latency | 0.84385422 |
| 78 | MP0008874_decreased_physiological_sensi | 0.84127657 |
| 79 | MP0008004_abnormal_stomach_pH | 0.80217104 |
| 80 | MP0003075_altered_response_to | 0.78665650 |
| 81 | MP0001968_abnormal_touch/_nociception | 0.78044859 |
| 82 | MP0001663_abnormal_digestive_system | 0.75548384 |
| 83 | MP0005390_skeleton_phenotype | 0.74558199 |
| 84 | MP0002736_abnormal_nociception_after | 0.71388144 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.71269269 |
| 86 | MP0008569_lethality_at_weaning | 0.68871203 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.68675161 |
| 88 | MP0002735_abnormal_chemical_nociception | 0.67820244 |
| 89 | MP0003448_altered_tumor_morphology | 0.67415072 |
| 90 | MP0000249_abnormal_blood_vessel | 0.65085187 |
| 91 | MP0003806_abnormal_nucleotide_metabolis | 0.64293281 |
| 92 | MP0002075_abnormal_coat/hair_pigmentati | 0.63834276 |
| 93 | MP0003329_amyloid_beta_deposits | 0.63680300 |
| 94 | MP0002693_abnormal_pancreas_physiology | 0.63538810 |
| 95 | MP0003795_abnormal_bone_structure | 0.62742590 |
| 96 | MP0000371_diluted_coat_color | 0.62641707 |
| 97 | MP0005164_abnormal_response_to | 0.62462187 |
| 98 | MP0001905_abnormal_dopamine_level | 0.62299510 |
| 99 | MP0002254_reproductive_system_inflammat | 0.61531614 |
| 100 | MP0000313_abnormal_cell_death | 0.60511779 |
| 101 | MP0003077_abnormal_cell_cycle | 0.59362923 |
| 102 | MP0000604_amyloidosis | 0.58648125 |
| 103 | MP0008058_abnormal_DNA_repair | 0.57925811 |
| 104 | MP0005166_decreased_susceptibility_to | 0.57221916 |
| 105 | MP0009765_abnormal_xenobiotic_induced | 0.56276518 |
| 106 | MP0009764_decreased_sensitivity_to | 0.56229541 |
| 107 | MP0002083_premature_death | 0.55671654 |
| 108 | MP0005381_digestive/alimentary_phenotyp | 0.55186863 |
| 109 | MP0000343_altered_response_to | 0.54631799 |
| 110 | MP0003111_abnormal_nucleus_morphology | 0.54073919 |
| 111 | MP0003690_abnormal_glial_cell | 0.53848556 |
| 112 | MP0008007_abnormal_cellular_replicative | 0.53361769 |
| 113 | MP0002064_seizures | 0.53327578 |
| 114 | MP0003191_abnormal_cellular_cholesterol | 0.52876522 |
| 115 | MP0005535_abnormal_body_temperature | 0.52296366 |
| 116 | MP0004381_abnormal_hair_follicle | 0.52043290 |
| 117 | MP0008873_increased_physiological_sensi | 0.51226290 |
| 118 | MP0009763_increased_sensitivity_to | 0.50557803 |
| 119 | MP0003943_abnormal_hepatobiliary_system | 0.50263038 |
| 120 | MP0009745_abnormal_behavioral_response | 0.50152765 |
| 121 | MP0003045_fibrosis | 0.48235464 |
| 122 | MP0004130_abnormal_muscle_cell | 0.48204964 |
| 123 | MP0000609_abnormal_liver_physiology | 0.48104415 |
| 124 | MP0003787_abnormal_imprinting | 0.47841827 |
| 125 | MP0003453_abnormal_keratinocyte_physiol | 0.46565393 |
| 126 | MP0002653_abnormal_ependyma_morphology | 0.46500088 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.30146825 |
| 2 | Agammaglobulinemia (HP:0004432) | 4.90234380 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.72008542 |
| 4 | IgM deficiency (HP:0002850) | 4.61523012 |
| 5 | Cellulitis (HP:0100658) | 4.52853939 |
| 6 | Chronic otitis media (HP:0000389) | 4.43319547 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.37648797 |
| 8 | Thyroiditis (HP:0100646) | 4.26222612 |
| 9 | Meningitis (HP:0001287) | 4.21335112 |
| 10 | Eczematoid dermatitis (HP:0000976) | 4.16776566 |
| 11 | Recurrent viral infections (HP:0004429) | 4.13524608 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.06207550 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 3.97892491 |
| 14 | Myositis (HP:0100614) | 3.75582081 |
| 15 | Recurrent bronchitis (HP:0002837) | 3.75419421 |
| 16 | B lymphocytopenia (HP:0010976) | 3.73277310 |
| 17 | Abnormality of B cell number (HP:0010975) | 3.73277310 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 3.61155526 |
| 19 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.61155526 |
| 20 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.61155526 |
| 21 | Recurrent skin infections (HP:0001581) | 3.59038215 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.55498036 |
| 23 | Obstructive lung disease (HP:0006536) | 3.55498036 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.52055136 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.46856702 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.46856702 |
| 27 | Gastrointestinal infarctions (HP:0005244) | 3.36890524 |
| 28 | Thrombocytosis (HP:0001894) | 3.28994688 |
| 29 | Abnormality of the fingertips (HP:0001211) | 3.26277366 |
| 30 | Spontaneous hematomas (HP:0007420) | 3.25847550 |
| 31 | Inflammation of the large intestine (HP:0002037) | 3.20378731 |
| 32 | Gastrointestinal inflammation (HP:0004386) | 3.17547301 |
| 33 | Osteomyelitis (HP:0002754) | 3.14715503 |
| 34 | Prolonged bleeding time (HP:0003010) | 3.14021447 |
| 35 | Verrucae (HP:0200043) | 3.11387659 |
| 36 | Papilloma (HP:0012740) | 3.11387659 |
| 37 | Vasculitis (HP:0002633) | 3.07193409 |
| 38 | Mediastinal lymphadenopathy (HP:0100721) | 3.06757190 |
| 39 | T lymphocytopenia (HP:0005403) | 3.05358772 |
| 40 | Stomatitis (HP:0010280) | 2.99882243 |
| 41 | Lymphopenia (HP:0001888) | 2.99852466 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.97167212 |
| 43 | Abnormality of T cells (HP:0002843) | 2.96351628 |
| 44 | Dysostosis multiplex (HP:0000943) | 2.93621289 |
| 45 | Gastrointestinal stroma tumor (HP:0100723) | 2.93592142 |
| 46 | Urticaria (HP:0001025) | 2.91815651 |
| 47 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.89257304 |
| 48 | Colitis (HP:0002583) | 2.88095003 |
| 49 | Abnormality of T cell number (HP:0011839) | 2.87718770 |
| 50 | Chronic sinusitis (HP:0011109) | 2.86094542 |
| 51 | Severe combined immunodeficiency (HP:0004430) | 2.85912743 |
| 52 | Sepsis (HP:0100806) | 2.79476617 |
| 53 | Recurrent pneumonia (HP:0006532) | 2.79289060 |
| 54 | Abnormality of T cell physiology (HP:0011840) | 2.78593832 |
| 55 | Recurrent sinusitis (HP:0011108) | 2.72678644 |
| 56 | IgG deficiency (HP:0004315) | 2.69772081 |
| 57 | Autoimmune thrombocytopenia (HP:0001973) | 2.67581251 |
| 58 | Keratoconjunctivitis (HP:0001096) | 2.62727419 |
| 59 | Eosinophilia (HP:0001880) | 2.60079576 |
| 60 | Petechiae (HP:0000967) | 2.59529028 |
| 61 | Epistaxis (HP:0000421) | 2.58541748 |
| 62 | Abnormality of eosinophils (HP:0001879) | 2.54608574 |
| 63 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.53175259 |
| 64 | Gingivitis (HP:0000230) | 2.51159096 |
| 65 | Purpura (HP:0000979) | 2.49336202 |
| 66 | Leukocytosis (HP:0001974) | 2.48553049 |
| 67 | Increased IgE level (HP:0003212) | 2.47531077 |
| 68 | Optic neuritis (HP:0100653) | 2.47449846 |
| 69 | Retrobulbar optic neuritis (HP:0100654) | 2.47449846 |
| 70 | Increased IgM level (HP:0003496) | 2.46467395 |
| 71 | Acute lymphatic leukemia (HP:0006721) | 2.45911743 |
| 72 | Combined immunodeficiency (HP:0005387) | 2.45821353 |
| 73 | Chronic diarrhea (HP:0002028) | 2.45618575 |
| 74 | Systemic lupus erythematosus (HP:0002725) | 2.45036253 |
| 75 | Hypochromic anemia (HP:0001931) | 2.44334411 |
| 76 | Episodic fever (HP:0001954) | 2.43719288 |
| 77 | Hypoplasia of the thymus (HP:0000778) | 2.43436488 |
| 78 | Granulocytopenia (HP:0001913) | 2.43252397 |
| 79 | Recurrent lower respiratory tract infections (HP:0002783) | 2.39007439 |
| 80 | Abnormality of the prostate (HP:0008775) | 2.35923128 |
| 81 | Encephalitis (HP:0002383) | 2.35561104 |
| 82 | Increased serum ferritin (HP:0003281) | 2.35035805 |
| 83 | Lymphoma (HP:0002665) | 2.30286964 |
| 84 | Pulmonary embolism (HP:0002204) | 2.30038563 |
| 85 | Periodontitis (HP:0000704) | 2.29195298 |
| 86 | Chest pain (HP:0100749) | 2.29143827 |
| 87 | Nasal polyposis (HP:0100582) | 2.27426515 |
| 88 | Orchitis (HP:0100796) | 2.27092993 |
| 89 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.26303881 |
| 90 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.26303881 |
| 91 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.26303881 |
| 92 | Papilledema (HP:0001085) | 2.24498026 |
| 93 | Increased cerebral lipofuscin (HP:0011813) | 2.24022123 |
| 94 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.23678642 |
| 95 | Hemoptysis (HP:0002105) | 2.22466110 |
| 96 | Interstitial pulmonary disease (HP:0006530) | 2.21814439 |
| 97 | Vacuolated lymphocytes (HP:0001922) | 2.21525024 |
| 98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.21155476 |
| 99 | Amyloidosis (HP:0011034) | 2.17851993 |
| 100 | IgA deficiency (HP:0002720) | 2.14479665 |
| 101 | Hepatosplenomegaly (HP:0001433) | 2.11171003 |
| 102 | Anorexia (HP:0002039) | 2.10343855 |
| 103 | Skin rash (HP:0000988) | 2.10055481 |
| 104 | Abnormality of iron homeostasis (HP:0011031) | 2.09235187 |
| 105 | Restrictive lung disease (HP:0002091) | 2.08586408 |
| 106 | Abnormality of the pleura (HP:0002103) | 2.07886331 |
| 107 | Hematochezia (HP:0002573) | 2.07549436 |
| 108 | Hypochromic microcytic anemia (HP:0004840) | 2.07156037 |
| 109 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05984255 |
| 110 | Mucopolysacchariduria (HP:0008155) | 2.05984255 |
| 111 | Hypergammaglobulinemia (HP:0010702) | 2.05970211 |
| 112 | Neutropenia (HP:0001875) | 2.05679593 |
| 113 | Abnormality of the nasal mucosa (HP:0000433) | 2.04709258 |
| 114 | Gingival bleeding (HP:0000225) | 2.04571610 |
| 115 | Slow saccadic eye movements (HP:0000514) | 2.04095586 |
| 116 | Pulmonary infiltrates (HP:0002113) | 2.03103776 |
| 117 | Mutism (HP:0002300) | 2.02059773 |
| 118 | Disinhibition (HP:0000734) | 2.01613746 |
| 119 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.00681173 |
| 120 | Neuronal loss in central nervous system (HP:0002529) | 1.98055016 |
| 121 | Premature loss of primary teeth (HP:0006323) | 1.94317196 |
| 122 | Keratoconjunctivitis sicca (HP:0001097) | 1.93986972 |
| 123 | Loss of speech (HP:0002371) | 1.93768013 |
| 124 | Skin ulcer (HP:0200042) | 1.93556515 |
| 125 | Pustule (HP:0200039) | 1.92591627 |
| 126 | Emphysema (HP:0002097) | 1.92336189 |
| 127 | Arterial thrombosis (HP:0004420) | 1.89952611 |
| 128 | Abnormal platelet function (HP:0011869) | 1.89948292 |
| 129 | Impaired platelet aggregation (HP:0003540) | 1.89948292 |
| 130 | Autoimmune hemolytic anemia (HP:0001890) | 1.86183244 |
| 131 | Leukopenia (HP:0001882) | 1.85582812 |
| 132 | Acute myeloid leukemia (HP:0004808) | 1.83764257 |
| 133 | Abnormality of DNA repair (HP:0003254) | 1.81058600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.02345520 |
| 2 | FES | 3.01975662 |
| 3 | KIT | 3.01668063 |
| 4 | BLK | 2.90439832 |
| 5 | RIPK4 | 2.88865248 |
| 6 | IRAK4 | 2.84453099 |
| 7 | TXK | 2.57379435 |
| 8 | SYK | 2.55531913 |
| 9 | CSF1R | 2.48240036 |
| 10 | BTK | 2.43689746 |
| 11 | EEF2K | 2.40928696 |
| 12 | SIK2 | 2.33304054 |
| 13 | CLK1 | 2.11693788 |
| 14 | MAP3K13 | 2.00279909 |
| 15 | ZAP70 | 1.98979392 |
| 16 | MAP3K10 | 1.97631592 |
| 17 | GRK6 | 1.91167519 |
| 18 | TEC | 1.86186804 |
| 19 | MAP3K11 | 1.86038474 |
| 20 | TYK2 | 1.74848380 |
| 21 | JAK3 | 1.71282618 |
| 22 | TAOK1 | 1.69729481 |
| 23 | IKBKE | 1.69503673 |
| 24 | HCK | 1.66626444 |
| 25 | MAP3K14 | 1.63464581 |
| 26 | ITK | 1.56089190 |
| 27 | LCK | 1.53834619 |
| 28 | TAOK3 | 1.49902401 |
| 29 | TRIB3 | 1.44703298 |
| 30 | EPHB1 | 1.43549386 |
| 31 | FLT3 | 1.42339960 |
| 32 | MAP3K3 | 1.39434002 |
| 33 | LYN | 1.33541560 |
| 34 | TBK1 | 1.32703733 |
| 35 | CDK19 | 1.24425733 |
| 36 | SIK3 | 1.18288720 |
| 37 | JAK1 | 1.14807957 |
| 38 | MAP3K1 | 1.13327574 |
| 39 | STK10 | 1.07692162 |
| 40 | TESK2 | 1.06935743 |
| 41 | TAOK2 | 1.04553253 |
| 42 | MAP3K12 | 1.01161527 |
| 43 | MAP2K3 | 1.00895898 |
| 44 | TNK2 | 0.95209201 |
| 45 | ERN1 | 0.94972639 |
| 46 | CAMKK2 | 0.94451744 |
| 47 | IKBKB | 0.92233821 |
| 48 | FGFR3 | 0.91311509 |
| 49 | IRAK1 | 0.89138841 |
| 50 | SIK1 | 0.87081287 |
| 51 | SMG1 | 0.86841550 |
| 52 | IRAK2 | 0.83734317 |
| 53 | HIPK2 | 0.83010750 |
| 54 | CSK | 0.79463617 |
| 55 | DAPK1 | 0.78863003 |
| 56 | PRKCQ | 0.78132013 |
| 57 | CDC42BPA | 0.77600010 |
| 58 | TRPM7 | 0.74502805 |
| 59 | PIM1 | 0.73237041 |
| 60 | PRPF4B | 0.72383707 |
| 61 | KSR2 | 0.71527638 |
| 62 | MAPK4 | 0.70796520 |
| 63 | CCNB1 | 0.69333120 |
| 64 | MATK | 0.67577740 |
| 65 | ADRBK2 | 0.67390752 |
| 66 | TNIK | 0.66872890 |
| 67 | PRKCH | 0.66812402 |
| 68 | PDPK1 | 0.66382461 |
| 69 | DYRK1B | 0.66158515 |
| 70 | PTK6 | 0.65104029 |
| 71 | IRAK3 | 0.64636238 |
| 72 | PDK1 | 0.63506697 |
| 73 | FGFR2 | 0.61791560 |
| 74 | MAPKAPK5 | 0.61139130 |
| 75 | EPHA3 | 0.60795075 |
| 76 | CDK4 | 0.60304763 |
| 77 | BMPR2 | 0.57068667 |
| 78 | TGFBR2 | 0.56820744 |
| 79 | MAPK12 | 0.55764176 |
| 80 | BRD4 | 0.55201047 |
| 81 | MAP3K7 | 0.54473452 |
| 82 | STK16 | 0.53252422 |
| 83 | ATR | 0.52903646 |
| 84 | GRK7 | 0.52440964 |
| 85 | YES1 | 0.50984518 |
| 86 | STK4 | 0.50481337 |
| 87 | LRRK2 | 0.50139121 |
| 88 | KDR | 0.50079226 |
| 89 | PASK | 0.49782845 |
| 90 | NLK | 0.49435276 |
| 91 | JAK2 | 0.48617548 |
| 92 | UHMK1 | 0.48014452 |
| 93 | RPS6KA6 | 0.47701381 |
| 94 | MAP2K6 | 0.47383118 |
| 95 | MAPK7 | 0.47372604 |
| 96 | DAPK2 | 0.46265004 |
| 97 | FYN | 0.46101415 |
| 98 | NEK2 | 0.45792439 |
| 99 | TGFBR1 | 0.42668621 |
| 100 | ICK | 0.41895737 |
| 101 | MARK3 | 0.41227135 |
| 102 | PRKCD | 0.41145716 |
| 103 | STK11 | 0.41138343 |
| 104 | MAP3K6 | 0.40822780 |
| 105 | CAMKK1 | 0.40571501 |
| 106 | EIF2AK3 | 0.40530764 |
| 107 | FGFR4 | 0.40214563 |
| 108 | CDC7 | 0.39994778 |
| 109 | MAP2K2 | 0.39802900 |
| 110 | FRK | 0.39635783 |
| 111 | RPS6KA2 | 0.39039639 |
| 112 | RPS6KC1 | 0.37579587 |
| 113 | RPS6KL1 | 0.37579587 |
| 114 | SCYL2 | 0.36713651 |
| 115 | MARK2 | 0.36256865 |
| 116 | MAPK11 | 0.36096362 |
| 117 | CAMK4 | 0.35041765 |
| 118 | RET | 0.34694825 |
| 119 | MAP3K5 | 0.34208834 |
| 120 | CDK12 | 0.30813467 |
| 121 | CAMK1 | 0.30557302 |
| 122 | PIM2 | 0.30471165 |
| 123 | CHUK | 0.29907368 |
| 124 | FGR | 0.28860857 |
| 125 | BRSK1 | 0.27792681 |
| 126 | RPS6KB2 | 0.27104330 |
| 127 | PKN2 | 0.26682384 |
| 128 | PRKD2 | 0.26130006 |
| 129 | ABL1 | 0.25710565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.28749596 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.18665702 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.48316781 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.44232779 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.40199483 |
| 6 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.13936111 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.13728105 |
| 8 | DNA replication_Homo sapiens_hsa03030 | 2.07146213 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99879518 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.93907306 |
| 11 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.93604570 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.93243807 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.88354388 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.87222897 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.77918428 |
| 16 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.62609158 |
| 17 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.59308136 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.52765713 |
| 19 | Base excision repair_Homo sapiens_hsa03410 | 1.48685220 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.44507638 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.43044226 |
| 22 | Mismatch repair_Homo sapiens_hsa03430 | 1.39662359 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38119436 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.35273600 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.34574563 |
| 26 | Platelet activation_Homo sapiens_hsa04611 | 1.33314272 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.33188179 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.29501775 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.28509715 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.26571073 |
| 31 | Allograft rejection_Homo sapiens_hsa05330 | 1.25621293 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.23328291 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22474660 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19685896 |
| 35 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.14836694 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.09889065 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.09858739 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08830364 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.07485443 |
| 40 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07090856 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.05653698 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05573870 |
| 43 | Asthma_Homo sapiens_hsa05310 | 1.04978405 |
| 44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04708950 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02338453 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 0.99956779 |
| 47 | Homologous recombination_Homo sapiens_hsa03440 | 0.99486949 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97217018 |
| 49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95601706 |
| 50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.93812049 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.89813638 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87708070 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 0.87705573 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85913456 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85661204 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84565409 |
| 57 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83305963 |
| 58 | Olfactory transduction_Homo sapiens_hsa04740 | 0.82399419 |
| 59 | Malaria_Homo sapiens_hsa05144 | 0.82216084 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80254645 |
| 61 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.77299643 |
| 62 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73999019 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.71758427 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70753517 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69132996 |
| 66 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68574194 |
| 67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.68451590 |
| 68 | Morphine addiction_Homo sapiens_hsa05032 | 0.68142723 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66938049 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66612383 |
| 71 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63770046 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63397943 |
| 73 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62991782 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62990424 |
| 75 | Legionellosis_Homo sapiens_hsa05134 | 0.62814750 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.62644241 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62355680 |
| 78 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.62089457 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61033394 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.60592207 |
| 81 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60102331 |
| 82 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.59551204 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59466247 |
| 84 | Phagosome_Homo sapiens_hsa04145 | 0.58715657 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57728456 |
| 86 | Ribosome_Homo sapiens_hsa03010 | 0.54526602 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54103707 |
| 88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53647531 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.53313020 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53201968 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53017978 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52326057 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51048936 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50891779 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48794366 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48469408 |
| 97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48112677 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47472314 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.47376693 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47325084 |
| 101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46727125 |
| 102 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46160118 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45769105 |
| 104 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.45682272 |
| 105 | Long-term potentiation_Homo sapiens_hsa04720 | 0.45496879 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.43944769 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43834910 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43342389 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43258817 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.41866294 |
| 111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.40397007 |
| 112 | Spliceosome_Homo sapiens_hsa03040 | 0.39296907 |
| 113 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39204521 |
| 114 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38452634 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37886283 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.33215009 |
| 117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31658730 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.31205566 |
| 119 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28510458 |
| 120 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.27896636 |

